RIM
MRNA icon

Rockbridge Investment Management’s Moderna MRNA Stock Holding History

Rockbridge Investment Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10
Closed -$995 – 435
2023
Q4 		$995 Buy
+10
New +$841 ﹤0.01% 581
2022
Q3 		– Sell
-10
Closed -$1.43K – 409
2022
Q2 		$1.43K Sell
10
-45
-82% -$6.43K ﹤0.01% 560
2022
Q1 		$9.71K Sell
55
-10
-15% -$1.68K ﹤0.01% 515
2021
Q4 		$17K Buy
65
+45
+225% +$13.2K ﹤0.01% 500
2021
Q3 		$8K Buy
+20
New +$7.38K ﹤0.01% 552
2021
Q2 		– Sell
-123
Closed -$16K – 744
2021
Q1 		$16K Hold
123
– – ﹤0.01% 445
2020
Q4 		$13K Buy
+123
New +$12.4K ﹤0.01% 477

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Rockbridge Investment Management's MRNA Position: Q1 2024 in Review

Rockbridge Investment Management sold out of Moderna (MRNA) in Q1 2024, closing a stake of 10 shares — an estimated $995 sold.

Rockbridge Investment Management first reported a position in MRNA in Q4 2020 and held it in 7 quarters. The position peaked at $17K in Q4 2021. 902 funds tracked by Wall St. Rank hold MRNA as of Q1 2024.

  • Rockbridge Investment Management reported no remaining Moderna position as of Q1 2024 after selling out during the quarter.
  • Rockbridge Investment Management sold 10 Moderna shares in Q1 2024, an estimated $995.
  • Rockbridge Investment Management first reported a position in Moderna in Q4 2020 and held it in 7 quarters.
  • Rockbridge Investment Management's Moderna position peaked at $17K in Q4 2021.
  • 902 funds tracked by Wall St. Rank held Moderna as of Q1 2024.

Based on Rockbridge Investment Management's 13F filing for Q1 2024, filed 15 May 2024.